TREATMENT OF BLOOD CANCER
- 专利权人:
- Karen Curd
- 发明人:
- John Curd,Damian Handisides,Charles Hart,Stewart Kroll
- 申请号:
- US13806088
- 公开号:
- US20130296273A1
- 申请日:
- 2011.06.27
- 申请国别(地区):
- US
- 年份:
- 2013
- 代理人:
- 摘要:
- Hypoxia activated prodrugs, such as, e.g., TH-281, TH-302, and TH-308, are useful for the treatment of various blood cancers, such as acute leukemias, chronic leukemias, MDS, MF, and multiple myeloma.
- 来源网站:
- 中国工程科技知识中心